Is Haemonetics Corp (NYSE: HAE) No Longer A Good Investment?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

Stocks Info

HAE belongs to the Healthcare sector of the NYSE while operating in the Medical Instruments & Supplies industry. The current market capitalization of Haemonetics Corp is $3.17B. A total of 0.99 million shares were traded on the day, compared to an average of 788.96K shares.

In the most recent transaction, Lingamneni Anila bought 6,238 shares of HAE for 90.68 per share on Nov 11 ’24. In a previous transaction on Jul 26 ’24, Strong Stewart W sold 4,312 shares at 91.15 per share. HAE shares that President, Global Hospital owns now total 18,196.

Among the insiders who bought shares, Strong Stewart W acquired of 4,312 shares on Jul 26 ’24 at a per-share price of $91.15. In another insider transaction, Lingamneni Anila sold 2,136 shares at $90.00 per share on Jul 11 ’24. Company shares held by the EVP, Chief Technology Officer now total 21,410.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, HAE has a high of $97.97 and a low of $58.80.

As of this writing, HAE has an earnings estimate of $1.22 per share for the current quarter. EPS was calculated based on a consensus of 10.0 estimates, with a high estimate of $1.28 per share and a lower estimate of $1.17.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. HAE’s latest balance sheet shows that the firm has $259.50M in Cash & Short Term Investments as of fiscal 2022. There were $773.59M in debt and $442.27M in liabilities at the time. Its Book Value Per Share was $18.05, while its Total Shareholder’s Equity was $749.42M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for HAE is Buy with a score of 4.33.

Most Popular

Related Posts